About Laxmi Therapeutic Devices
Laxmi Therapeutic Devices is a private company based in Goleta, California. It has reported $60,350,642 raised in ten offerings on Form D since July 2016. Its chief executive is Peter Rule.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 14, 2026 | $2,150,000fully sold | 5 | $430K | Debt, Options, Securities on exercise, Convertible NotesRule 506(b) | Form D ↗ |
| Jul 31, 2024 | Aug 1, 2024amended Feb 21, 2025 | $14,999,999of $15.0M target | 5 | $2.9M | Equity, Series Seed VII Preferred StockRule 506(b) | Form D/A ↗4 earlier filings |
| Nov 29, 2023 | Nov 30, 2023 | $5,000,000fully sold | 4 | $1.2M | Equity, Series Seed VI PreferredRule 506(b) | Form D ↗ |
| Jul 26, 2022 | Jul 26, 2022 | $8,999,998fully sold | 6 | $1.4M | Equity, Series Seed V PreferredRule 506(b) | Form D ↗ |
| Mar 3, 2021 | Apr 12, 2021 | $13,200,000fully sold | 4 | $3.3M | Equity, Series Seed V PreferredRule 506(b) | Form D ↗ |
| Jun 1, 2020 | Jun 4, 2020amended Oct 28, 2020 | $6,000,000fully sold | 2 | $3.0M | Equity, Series Seed IV PreferredRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 2, 2019 | Dec 4, 2019 | $6,000,000fully sold | 3 | $2.0M | Equity, Series Seed III PreferredRule 506(b) | Form D ↗ |
| Oct 30, 2017 | Nov 7, 2017amended Dec 14, 2017 | $2,500,025fully sold | 2 | $1.2M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 15, 2016 | Jul 19, 2016 | $1,500,000fully sold | 1 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Jul 6, 2016 | Jul 13, 2016 | $620fully sold | 5 | $124 | EquityRule 506(b) | Form D ↗ |
| Total, ten offerings | $60,350,642 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Laxmi Therapeutic Devices's Form D filed Jul 14, 2026.
Earlier filings also listed John Gerngross (secretary and director, last listed Feb 2025), Rachael Scherer (director, last listed Jul 2022), Bill Van Antwerp (director, last listed Jul 2022), Radhika Krishnan (director, last listed Oct 2020), Radhika Krishman (director, last listed Dec 2019), Bill Van Antwery (director, last listed Dec 2019), Richard Low (director, last listed Dec 2017) and Luke Theogarajan (executive officer and director, last listed Dec 2017).
Sources
- SECLaxmi Therapeutic Devices, Inc. Form D/A, filed Jan 21, 2025
- SECLaxmi Therapeutic Devices, Inc. Form D/A, filed Jan 10, 2025
- SECLaxmi Therapeutic Devices, Inc. Form D/A, filed Oct 1, 2024
- SECLaxmi Therapeutic Devices, Inc. Form D, filed Aug 1, 2024
- SECLaxmi Therapeutic Devices, Inc. Form D, filed Jun 4, 2020
- SECLaxmi Therapeutic Devices, Inc. Form D, filed Nov 7, 2017
- SECLaxmi Therapeutic Devices, Inc. filing history
- CompanyTeam
- CompanyPrivacy policy